Literature DB >> 11431691

Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia.

Z Ma1, S W Morris, V Valentine, M Li, J A Herbrick, X Cui, D Bouman, Y Li, P K Mehta, D Nizetic, Y Kaneko, G C Chan, L C Chan, J Squire, S W Scherer, J K Hitzler.   

Abstract

t(1;22) is the principal translocation of acute megakaryoblastic leukemias. Here we show this chromosomal rearrangement to result in the fusion of two novel genes, RNA-binding motif protein-15 (RBM15), an RNA recognition motif-encoding gene with homology to Drosophila spen, and Megakaryoblastic Leukemia-1 (MKL1), a gene encoding an SAP (SAF-A/B, Acinus and PIAS) DNA-binding domain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11431691     DOI: 10.1038/90054

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  107 in total

1.  A conserved structural motif reveals the essential transcriptional repression function of Spen proteins and their role in developmental signaling.

Authors:  Mariko Ariyoshi; John W R Schwabe
Journal:  Genes Dev       Date:  2003-08-01       Impact factor: 11.361

2.  JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model.

Authors:  Thomas Mercher; Gerlinde Wernig; Sandra A Moore; Ross L Levine; Ting-Lei Gu; Stefan Fröhling; Dana Cullen; Roberto D Polakiewicz; Olivier A Bernard; Titus J Boggon; Benjamin H Lee; D Gary Gilliland
Journal:  Blood       Date:  2006-06-27       Impact factor: 22.113

3.  Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling.

Authors:  Jean-Pierre Bourquin; Aravind Subramanian; Claudia Langebrake; Dirk Reinhardt; Olivier Bernard; Paola Ballerini; André Baruchel; Hélène Cavé; Nicole Dastugue; Henrik Hasle; Gertjan L Kaspers; Michel Lessard; Lucienne Michaux; Paresh Vyas; Elisabeth van Wering; Christian M Zwaan; Todd R Golub; Stuart H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

4.  The RNA binding motif protein 15B (RBM15B/OTT3) is a functional competitor of serine-arginine (SR) proteins and antagonizes the positive effect of the CDK11p110-cyclin L2α complex on splicing.

Authors:  Pascal Loyer; Adeline Busson; Janeen H Trembley; Judith Hyle; Jose Grenet; Wei Zhao; Catherine Ribault; Tristan Montier; Vincent J Kidd; Jill M Lahti
Journal:  J Biol Chem       Date:  2010-11-02       Impact factor: 5.157

Review 5.  Normal and malignant megakaryopoiesis.

Authors:  Qiang Wen; Benjamin Goldenson; John D Crispino
Journal:  Expert Rev Mol Med       Date:  2011-10-21       Impact factor: 5.600

6.  Basic research in paediatrics: Does it exist?

Authors:  Manuel Buchwald
Journal:  Paediatr Child Health       Date:  2004-07       Impact factor: 2.253

7.  Hematopoietic disorders in Down syndrome.

Authors:  John K Choi
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

8.  Fusion of OTT to BSAC results in aberrant up-regulation of transcriptional activity.

Authors:  Taisuke Sawada; Chiharu Nishiyama; Takuma Kishi; Tomonari Sasazuki; Sachiko Komazawa-Sakon; Xin Xue; Jiang-Hu Piao; Hideko Ogata; Jun-ichi Nakayama; Tomohiko Taki; Yasuhide Hayashi; Mamoru Watanabe; Hideo Yagita; Ko Okumura; Hiroyasu Nakano
Journal:  J Biol Chem       Date:  2008-07-30       Impact factor: 5.157

9.  Induction of megakaryocyte differentiation drives nuclear accumulation and transcriptional function of MKL1 via actin polymerization and RhoA activation.

Authors:  Elenoe C Smith; Alexandra M Teixeira; Rachel C Chen; Lin Wang; Yuan Gao; Katherine L Hahn; Diane S Krause
Journal:  Blood       Date:  2012-12-14       Impact factor: 22.113

10.  Ott1 (Rbm15) is essential for placental vascular branching morphogenesis and embryonic development of the heart and spleen.

Authors:  Glen D Raffel; Gerald C Chu; Jonathan L Jesneck; Dana E Cullen; Roderick T Bronson; Olivier A Bernard; D Gary Gilliland
Journal:  Mol Cell Biol       Date:  2008-11-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.